[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT87913A - Processo para a preparacao de derivados de benzopirano e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de benzopirano e de composicoes farmaceuticas que os contem

Info

Publication number
PT87913A
PT87913A PT87913A PT8791388A PT87913A PT 87913 A PT87913 A PT 87913A PT 87913 A PT87913 A PT 87913A PT 8791388 A PT8791388 A PT 8791388A PT 87913 A PT87913 A PT 87913A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
benzopyran derivatives
preparing
preparing benzopyran
Prior art date
Application number
PT87913A
Other languages
English (en)
Other versions
PT87913B (pt
Inventor
Sally Redshaw
Michael Richard Attwood
Philip Stephen Jones
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878715839A external-priority patent/GB8715839D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT87913A publication Critical patent/PT87913A/pt
Publication of PT87913B publication Critical patent/PT87913B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
PT87913A 1987-07-06 1988-07-05 Processo para a preparacao de derivados de benzopirano e de composicoes farmaceuticas que os contem PT87913B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878715839A GB8715839D0 (en) 1987-07-06 1987-07-06 Benzopyran derivatives
GB888810212A GB8810212D0 (en) 1987-07-06 1988-04-29 Benzopyran derivatives

Publications (2)

Publication Number Publication Date
PT87913A true PT87913A (pt) 1989-06-30
PT87913B PT87913B (pt) 1995-03-01

Family

ID=26292440

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87913A PT87913B (pt) 1987-07-06 1988-07-05 Processo para a preparacao de derivados de benzopirano e de composicoes farmaceuticas que os contem

Country Status (27)

Country Link
US (2) US4971982A (pt)
EP (1) EP0298452B1 (pt)
JP (1) JP2683581B2 (pt)
CN (1) CN1023404C (pt)
AR (1) AR245710A1 (pt)
AT (1) ATE91127T1 (pt)
AU (1) AU613646B2 (pt)
CA (1) CA1334094C (pt)
CZ (1) CZ285970B6 (pt)
DE (1) DE3882095D1 (pt)
DK (1) DK370988A (pt)
DZ (1) DZ1227A1 (pt)
ES (1) ES2056859T3 (pt)
FI (1) FI90079C (pt)
HU (2) HU202513B (pt)
IE (1) IE62258B1 (pt)
IL (1) IL86923A (pt)
IS (1) IS1596B (pt)
MC (1) MC1953A1 (pt)
MX (1) MX174083B (pt)
NO (1) NO170727C (pt)
NZ (1) NZ225163A (pt)
PH (1) PH27153A (pt)
PT (1) PT87913B (pt)
SK (1) SK279037B6 (pt)
SU (1) SU1757466A3 (pt)
YU (1) YU46918B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
DE3922392A1 (de) * 1989-07-07 1991-01-17 Merck Patent Gmbh Chromanderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
DE3926001A1 (de) * 1989-08-05 1991-02-07 Merck Patent Gmbh Chromanderivate
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
CN1060467A (zh) 1990-09-25 1992-04-22 武田药品工业株式会社 1，3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
DE4115465A1 (de) * 1991-05-11 1992-11-12 Beiersdorf Ag Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
FR2698873B1 (fr) * 1992-12-07 1995-02-24 Lipha Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
CN1044605C (zh) * 1992-08-17 1999-08-11 中外制药株式会社 苯并吡喃和苯并嗪衍生物
ES2064228B1 (es) * 1992-10-19 1995-09-01 Uriach & Cia Sa J Nuevas tetralonas con actividad farmacologica, composiciones que las contienen y procedimiento para su preparacion.
US5416097A (en) * 1993-05-19 1995-05-16 Berlex Laboratories, Inc. Potassium channel activators/openers
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
EP0677519A4 (en) * 1993-11-10 1996-04-03 Japan Tobacco Inc CHROMAN DERIVATIVE AND THERAPEUTIC USE THEREOF.
CA2191245A1 (en) * 1994-06-09 1995-12-14 Kazuo Yamazaki 4-quinolinone derivative or salt thereof
US5470861A (en) 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
KR100691511B1 (ko) * 1995-11-09 2007-04-19 다우 아그로사이언시즈 엘엘씨 크로만카복실레이트의제조방법
JP3885900B2 (ja) * 1996-03-22 2007-02-28 大日本インキ化学工業株式会社 ベンゾピラン誘導体及びそれを有効成分とする心臓疾患治療剤
WO1999001453A1 (en) * 1997-07-02 1999-01-14 F. Hoffmann-La Roche Ag A process for the manufacture of optically active chromanylpyridine derivatives
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6489344B1 (en) 1998-06-19 2002-12-03 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
AR035087A1 (es) * 2001-08-09 2004-04-14 Syngenta Participations Ag Piridil-alquinos y piridil-n-oxido-alquinos herbicidas activos, procedimiento para su preparacion, composicion herbicida y para inhibir el crecimiento de plantas, metodo para el control del crecimiento de plantas indeseables , y metodo para la inhibicion del crecimiento de plantas
AR040413A1 (es) * 2002-05-31 2005-04-06 Syngenta Participations Ag Heterociclilalquinos activos como herbicidas
CN101296731A (zh) * 2005-09-01 2008-10-29 詹森药业有限公司 作为钾通道开启剂的苯并吡喃和吡喃并吡啶衍生物
PT1937669E (pt) * 2005-09-01 2012-03-21 Janssen Pharmaceutica Nv Novos derivados do benzopirano como abridores de canais de potássio
WO2008072801A1 (en) * 2006-12-13 2008-06-19 Seoul National University Industry Foundation Compounds with embedded benzopyran motif for core structures and preparation method thereof
CN103819395B (zh) * 2014-02-24 2016-05-25 蚌埠中实化学技术有限公司 一种制备2-碘-5-苯基吡啶的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583811A (en) * 1977-05-09 1981-02-04 Laroche Navarron Sa Chromene derivatives
US4563468A (en) * 1979-09-13 1986-01-07 Burroughs Wellcome Co. Chemotherapeutic agents
HU184359B (en) * 1980-12-16 1984-08-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing substituted acyl-carbamides
US4443459A (en) * 1981-05-26 1984-04-17 Banyu Pharmaceutical Co., Ltd. α-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
ATE56007T1 (de) * 1984-06-22 1990-09-15 Beecham Group Plc Wirksame benzopyranverbindungen.
DE3669317D1 (de) * 1985-09-11 1990-04-12 Beecham Group Plc Chromanderivate und aehnliche verbindungen mit blutdrucksenkender wirkung.
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
FI90343C (fi) * 1987-06-23 1994-01-25 Merck Patent Gmbh Menetelmä korkeaa verenpainetta alentavien ja rytmihäiriöitä vastustavien trans-2,2-dimetyylikroman-3-olijohdannaisten valmistamiseksi
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives

Also Published As

Publication number Publication date
IS3369A7 (is) 1989-01-07
MX12168A (es) 1993-10-01
HU202513B (en) 1991-03-28
CN1030582A (zh) 1989-01-25
HUT50152A (en) 1989-12-28
PT87913B (pt) 1995-03-01
US4971982A (en) 1990-11-20
CZ285970B6 (cs) 1999-12-15
NO883007L (no) 1989-01-09
CA1334094C (en) 1995-01-24
NO170727C (no) 1992-11-25
SK484188A3 (en) 1998-05-06
CN1023404C (zh) 1994-01-05
NZ225163A (en) 1991-04-26
DK370988D0 (da) 1988-07-04
FI883232A0 (fi) 1988-07-06
SU1757466A3 (ru) 1992-08-23
ES2056859T3 (es) 1994-10-16
EP0298452A3 (en) 1989-04-05
NO170727B (no) 1992-08-17
IE62258B1 (en) 1995-01-11
DK370988A (da) 1989-01-07
MX174083B (es) 1994-04-20
AR245710A1 (es) 1994-02-28
SK279037B6 (sk) 1998-05-06
FI90079C (fi) 1993-12-27
DZ1227A1 (fr) 2004-09-13
CZ484188A3 (cs) 1999-10-13
JP2683581B2 (ja) 1997-12-03
FI90079B (fi) 1993-09-15
NO883007D0 (no) 1988-07-05
IL86923A0 (en) 1988-11-30
IL86923A (en) 1994-02-27
YU46918B (sh) 1994-06-24
FI883232A (fi) 1989-01-07
EP0298452A2 (de) 1989-01-11
JPS6438087A (en) 1989-02-08
YU130288A (en) 1990-06-30
HU211870A9 (en) 1995-12-28
EP0298452B1 (de) 1993-06-30
US5118694A (en) 1992-06-02
IE882043L (en) 1989-01-06
DE3882095D1 (de) 1993-08-05
IS1596B (is) 1996-04-12
AU1855688A (en) 1989-01-12
AU613646B2 (en) 1991-08-08
MC1953A1 (fr) 1989-06-30
PH27153A (en) 1993-04-02
ATE91127T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
PT87913A (pt) Processo para a preparacao de derivados de benzopirano e de composicoes farmaceuticas que os contem
PT89009A (pt) Processo para a preparacao de novos derivados de fluorocitidina e composicoes farmaceuticas que os contem
PT89485A (pt) Processo para a preparacao de derivados dide-hidro de vitamina d3 e de composicoes farmaceuticas que os contem
PT89328A (pt) Processo para a preparacao de novos derivados da adenosina e de composicoes farmaceuticas que os contem
PT84569B (pt) Processo para a preparacao de tiazepinas e de composicoes farmaceuticas que os contem
PT81746B (pt) Processo para a preparacao de peptido-aldeidos e de composicoes farmaceuticas que os contem
PT87201A (pt) Processo para a preparacao de novos derivados de cefalosporina 3,7-substituida e de composicoes farmaceuticas que os contem
PT80724B (pt) Processo para a preparacao de novos derivados de gangliosidos e de composicoes farmaceuticas que os contem
PT90836A (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT80892B (pt) Processo para a preparacao de derivados da quoinona e de composicoes farmaceuticas que os contem
PT88914A (pt) Processo para a preparacao de polipeptidos e de composicoes farmaceuticas que os contem
PT83355B (pt) Processo para a preparacao de derivados de benzimidazole e de composicoes farmaceuticas que os contem
PT81041B (pt) Processo para a preparacao de derivados de etilenodiamina-monoamida e de composicoes farmaceuticas que os contem
PT93060A (pt) Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
PT80246B (pt) Processo para a preparacao de novos derivados de cefalosporina e de composicoes farmaceuticas que os contem
PT82984B (pt) Processo para a preparacao de derivados de poli-4-aminopirrole-2-carboxamido e de composicoes farmaceuticas que os contem
PT81659B (pt) Processo para a preparacao de aminoacil-labdanos e de composicoes farmaceuticas que os contem
PT91122A (pt) Processo para a preparacao de novos derivados amidinicos e guanidinicos e de composicoes farmaceuticas que os contem
PT88679A (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT94902A (pt) Processo para a preparacao de novos derivados de cromano e de composicoes farmaceuticas que os contem
PT90864A (pt) Processo para a preparacao de derivados de cromano e de composicoes farmaceuticas que os contem
PT87115A (pt) Processo para a preparacao de derivados da dihidropiridazinona e de composicoes farmaceuticas que os contem
PT93290A (pt) Processo para a preparacao de novos eteres heterociclicos e de composicoes farmaceuticas que os contem
PT91803A (pt) Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem
PT87090A (pt) Processo para a preparacao de derivados de imidazopiridinas e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940818

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20010228